PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-8.32%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$629M
AUM Growth
+$629M
(-24%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
47.7%
Holding
242
New
26
Increased
27
Reduced
24
Closed
38
Top Buys
| 1 |
Glaukos
GKOS
|
$36.2M |
| 2 |
Guardant Health
GH
|
$16.2M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$13.9M |
| 4 |
Lyra Therapeutics
LYRA
|
$11.6M |
| 5 |
Pulmonx
LUNG
|
$10.9M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$19M |
| 2 |
C4 Therapeutics
CCCC
|
$15.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.5M |
| 4 |
ICU Medical
ICUI
|
$12.8M |
| 5 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
$11.3M |
Sector Composition
| 1 | Healthcare | 90.17% |
| 2 | Industrials | 0.83% |
| 3 | Consumer Staples | 0.74% |
| 4 | Materials | 0.31% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Teleflex
TFX
$5.56B
| – | – |
0
| – | – |
|
227
Tenet Healthcare
THC
$16.5B
| – | – |
0
| – | – |
|
228
Thermo Fisher Scientific
TMO
$183B
| – | – |
0
| – | – |
|
229
Tandem Diabetes Care
TNDM
$837M
| – | – |
0
| – | – |
|
230
Tango Therapeutics
TNGX
$732M
| – | – |
-82,727
| Closed | -$627K |
|
231
Trupanion
TRUP
$1.93B
| – | – |
0
| – | – |
|
232
10x Genomics
TXG
$1.66B
| – | – |
-22,257
| Closed | -$1.69M |
|
233
TherapeuticsMD
TXMD
$12.7M
| – | – |
-1,619,080
| Closed | -$615K |
|
234
Wave Life Sciences
WVE
$1.24B
| – | – |
-40,886
| Closed | -$82K |
|
235
Materials Select Sector SPDR Fund
XLB
$5.46B
| – | – |
0
| – | – |
|
236
SPDR NYSE Technology ETF
XNTK
$1.24B
| – | – |
0
| – | – |
|
237
Dentsply Sirona
XRAY
$2.74B
| – | – |
0
| – | – |
|
238
Zimmer Biomet
ZBH
$20.6B
| – | – |
0
| – | – |
|